BKA
CC icon

Brick & Kyle Associates’s Chemours CC Stock Holding History

Brick & Kyle Associates’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7
Closed – – 128
2017
Q1 		$0 Hold
7
– – ﹤0.01% 423
2016
Q4 		$0 Buy
+7
New +$144 ﹤0.01% 430
2016
Q3 		– Sell
-40
Closed – – 430
2016
Q2 		$0 Hold
40
– – ﹤0.01% 431
2016
Q1 		$0 Hold
40
– – ﹤0.01% 429
2015
Q4 		$0 Hold
40
– – ﹤0.01% 418
2015
Q3 		$0 Buy
+40
New +$419 ﹤0.01% 429

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brick & Kyle Associates's CC Position: Q2 2017 in Review

Brick & Kyle Associates sold out of Chemours (CC) in Q2 2017, closing a stake of 7 shares.

Brick & Kyle Associates first reported a position in CC in Q3 2015 and held it in 6 quarters. The position peaked at $0 in Q1 2017. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

  • Brick & Kyle Associates reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
  • Brick & Kyle Associates sold 7 Chemours shares in Q2 2017.
  • Brick & Kyle Associates first reported a position in Chemours in Q3 2015 and held it in 6 quarters.
  • Brick & Kyle Associates's Chemours position peaked at $0 in Q1 2017.
  • 462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.